



GRAYES' DISEASE IN A 5-YEAR-OLD CHILD
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Graves' disease in childhood and adolescence is still
regarded as a rarity outside the USA, from where the
only large series have originated.'·3 To our knowledge,
only neonatal Graves' disease, an equally rare but funda-
mentally different disorder, has been described in the
South African literature"
This fact, coupled with problems of therapy unique to
this age-group, prompts reporting of a single case.
Case Report
Two weeks following tonsillectomy in May 1965, I.M., a
5-year-old White female, became increasingly irritable, fidgety
and tremulous and began to sweat excessively. The right eye
became prominent, the weight dropped, and the appetite was
poor. Diarrhoea was not a feature. The mother noticed a
period of rapid growth preceding the onset of these symp-
toms.
Examination revealed a tall child (height 45 inches), who
was thin (weight 35 lb.), hyperactive and fidgety. A mild right-
sided proptosis was noted, as was a tachycardia of 160 beats/
min. and a diffuse, firm goitre (Fig. 1).
Fig. 1. Graves' disease in a 5-year-old child. Note the goitre and right
proptosis.
Neck uptakes of tracer doses of 1311 were 94% and 94%
at 6 and 24 hours respectively (upper limit of normal in our
laboratories 40% and 50%). Red blood cell uptake of tri-
iodothyronine (T3) was 46% (normal 13 - 19%) and serum
protein-bound iodine (PBI) was 18·6 ,ug./I00 ml. plasma
(normal 4 - 9 ,ug.). Radiologic estimation of bone age was 7
years (Fig. 2).
Thus far she has been on methimazole therapy (20 mg./
day) for 7 months and has improved progressively but very
slowly. She has gained 9 lb. in weight, is less irritable and
concentrates better at school. However, the pulse rate is still
110/min., the thyroid remains enlarged and a further 2t
inches of linear growth has occurred. Exophthalmos, however,
has regressed.
Fig. 2. Bone age estimated at 7 years (Pyle's Atlas) in a 5-year-old
thyrotoxic subject.
DISCUSSION
Recent reviews' ·' emphasize the clinical rarity of Graves'
disease in childhood. Even rarer is its occurrence under
the age of 5 years. Only 9 of 70 childhood cases reported
by Saxena et al.' fell into this group.
The full-blown clinical picture resembles the adult dis- .
order. However, early symptoms may be regarded as
psychosomatic in origin, and the diagnosis is often missed
until the disease is advanced. It is disturbing to note that
the interval between the onset of symptoms and diagnosis
exceeded one year in 10 of 33 cases recently reviewed.'
A growth spurt is often associated with the disorder, and
affected children are usually very tall with an advanced
epiphyseal bone age. Occasionally they develop puberty
precociously. Choreiform jerks are more common than
the classical fine tremor. Diarrhoea is less manifest than
in adulthood. Finally, psychic or other trauma appears to
be a precipitating factor in a high percentage of cases.'
The trauma of tonsillectomy might be incriminated in the
case reviewed.
Fifty percent of children have family members suffering
from thyroid disease,' raising the suspicion of genetic
transmission of the tendency to develop the disorder.
Ingbar et al." found elevated 1311 uptakes in 22% of relatives,
while Saxena7 showed that of 11 thyrotoxic children with
positive tanned red cell agglutination tests, 10 had a
parent with a positive result. He suggested the possible
importance of the genetic transmission of thyroglobulin
antibodies in tht: pathogenesis of childhood thyrotoxicosis.
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Regarding investigations, the PBI appears to be the
most reliable, though the RBC uptake of T3 and neck
uptake of 1311 are useful in following the progress of
the disease. The long-acting thyroid stimulator (LATS)
has been found in 3 of 17 cases,' an incidence distinctly
lower than that found in adult Graves' disease where it
approaches 60 - 75%.···
Neonatal thyrotoxicosis is a disorder with an entirely
different pathogenesis. It is self-limiting and is caused by
the placental transfer of LATS, a potent thyrotrophic
substance, from an actively or recently thyrotoxic mother.
Its course is limited by the temporary nature of circulating
LATS in the newborn. As LATS activity diminishes spon-
taneously over 4 - 8 weeks, so does that of the thyrotoxi-
cosis.
TREATMENT
In principle, thyrotoxicosis is treated along 3 main lines;
antithyroid medication, partial thyroidectomy, or 1:"1
ablation.
In the adult, antithyroid medication is largely used to
render the subject euthyroid before surgery. Because of
the necessity for its prolonged use and a high relapse
rate, it is rarely used as definitive treatment except in
young females with very mild hyperthyroidism, in some
pregnant thyrotoxics and in children; and even in the
latter instance, its use is contentious. Some authorities
regard this as the method of choice; but it may have to
be given for up to 4 years, and then only about 50% of
patients will remit permanently.'·'·lO The risk of the usual
side-effects is ever present. It is however inexpensive and
non-traumatic, an important consideration in childhood.
Partial thyroidectomy is the usual definitive treatment
of adult Graves' disease under the age of 35 or 40 years.
Its use is now standard and followed by a low rate of
complication, though authorities are questioning the
possible high incidence of subclinical hypoparathyroid-
ism.u In childhood, results of surgery are much less
uniform. Some report an 80% cure rate with negligible
complications,' while others mention a 25% incidence of
myxoedema.'· Saxena et al.' find difficulty in achieving a
compromise between a moderately extensive operation
(leaving 4 - 5 G thyroid) with no complications but a high
relapse rate on the one hand, and more extensive surgery
(leaving 1 G thyroid) and 100% cure, but a high incidence
of hypothyroidism and hypoparathyroidism, on the other.
1311 in ablative doses has found a permanent place in
the treatment of thyrotoxic patients over the age of 35 - 40
years. However, the rising long-term incidence of myxoe-
dema,"" currently estimated at 30% 10 years after com-
pletion of therapy," is causing some concern. In child-
hood there is much greater uncertainty regarding its use.
Sheline et al.H feel nodule formation to be a side-effect,
though others" are less certain of the correlation. A few
cases of thyroid carcinoma' and leukaemia have been re-
ported, but a statistical association is far from proven. No
congenital anomalies in offspring of persons who have
received 1311 therapeutically in childhood have been noted.'
Though this is a simple, untraumatic and effective form of
treatment, it is best avoided in childhood at present in
view of the prevailing uncertainties mentioned above.
We favour medical treatment initially, and methimazole
has been used in this case. This should be continued for
18 months. Jf relapse occurs on withdrawal of the drug,
surgery should be considered.
SUMMARY
A case of Graves' disease in a 5-year-old child is reported.
Diagnosis may present considerable initial difficulty, and a
delay of up to a year from the onset of symptoms is not
. uncommon. Therapy is largely unsatisfactory compared to the
adult disease--all forms have disadvantages. Long-term anti-
thyroid drug treatment is favoured, followed by surgery if the
disease relapses after withdrawal.
Dr. R. Hoffenberg very kindly read and commented on this
manuscript. Dr. J. G. Burger, Superintendent, Groote Schuur
Hospital, is thanked for permission to publish the case.
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,Die dae van ons jare--daarin is sewentig jaar of as ons
baie sterk is 80 jaar; en die uitnemendste daarvan is moeite
en verdriet, want gou gaan dit verby en ons vlieg daarheen.'
My rede vandag sal gaan oor die gerontologie of ouderdoms-
verskynsels-'n baie verwaarloosde afdeling van die medisyne,
maar een wat vir elkeen van ons belangriker word elke dag
wat ons ouer word. Ek sal probeer 'n kort oorsig gee van
sekere feite en teoriee in verband met ouderdomsverskynsels
om te kyk of dit nie moontlik is dat ons almal die honderdtal
kan haal nie. Ek het hierdie onderwerp gekies na aanleiding
van twee waardige ou Senekal dames wat onlangs oorlede is.
Een het 102 jaar gehaal en die ander 101. As 'n mens hoog-
*Presidentsrede.
bejaardes vra waaraan hulle hulle hoe ouderdom toeskrywe,
is die antwoorde baie teenstrydig. Sommige skryf dit toe aan
matigheid met drank sigarette en vrouens, ander weer net die
teenoorgestelde. Daar is ook die voorstanders van jogurt, rou,
bevrugte eiers en massiewe hormone-inspuitings-wat gelukkig
nou uit die mode is.
Nieteenstaande die vooruitgang in die medisyne oor 3,000
iaar, bly die Bybelse voorspelling van 'n lewensduur van 70
jaar en soms 80 jaar nog baie akkuraat. Die moderne medisyne
het we! die lewensverwagting van 'n pasgebore baba drama-
ties verleng gedurende die afgelope paar dekades, maar die
afgelope 100 jaar is nie veel gedoen om die lewe te verleng
van 'n persoon wat reeds die ouderdom van 65 jaar bereik
het nie. Al verskil is dat baie meer mense vandag die ouder-
